Cipla Ltd, India`s second largest drugmaker by market capitalisation, posted a 19 percent rise in quarterly profit, slightly above analysts` estimate.
Profit rose to 4.23 billion rupees ($65.21 million)in the second quarter ended Sept. 30, from 3.54 billion rupees a year earlier, the company said. http://bit.ly/2AmueVf
That compares with an average expectation of 4.2 billion rupees in profit, drawn from 18 analysts polled by Thomson Reuters I/B/E/S.
($1 = 64.8700 Indian rupees)
(This article has not been edited by Zeebiz editorial team and is auto-generated from an agency feed.)